tm
Seeing Is Believing
tm
Seeing Is Believing
AVTX is currently covered by 2 analysts with an average price target of $312.08. This is a potential upside of $307.2 (6295.08%) from yesterday's end of day stock price of $4.88.
Avalo Therapeutics's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of AVTX is 33.33% BUY and 66.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 22.22% with an average time for these price targets to be met of 3.33 days.
Highest price target for AVTX is $592, Lowest price target is $103, average price target is $180.
Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 27-Jun-2023. First documented stock forecast 18-Nov-2020.
Currently out of the existing stock ratings of AVTX, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$2400
1 years 9 months 28 days ago
(27-Jun-2023)
0/1 (0%)
$909.6 (61.03%)
Hold
$180
$175.59 (3981.63%)
1 years 9 months 29 days ago
(26-Jun-2023)
0/2 (0%)
$60 (50.00%)
Hold
$720
$711.82 (8701.96%)
$2160
2 years 2 months 16 days ago
(08-Feb-2023)
2/3 (66.67%)
$-48 (-6.25%)
10
What is AVTX (Avalo Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AVTX (Avalo Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AVTX (Avalo Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AVTX (Avalo Therapeutics)?
Which analyst is the currently most bullish on AVTX (Avalo Therapeutics)?
Which analyst is the currently most reserved on AVTX (Avalo Therapeutics)?
